Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome.

MLA

Mollbrink, A., et al. “Expression of Thioredoxins and Glutaredoxins in Human Hepatocellular Carcinoma: Correlation to Cell Proliferation, Tumor Size and Metabolic Syndrome.” International Journal of Immunopathology and Pharmacology, vol. 27, no. 2, Apr. 2014, pp. 169–83. EBSCOhost, https://doi.org/10.1177/039463201402700204.

APA

Mollbrink, A., Jawad, R., Vlamis-Gardikas, A., Edenvik, P., Isaksson, B., Danielsson, O., Stål, P., & Fernandes, A. P. (2014). Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome. International Journal of Immunopathology and Pharmacology, 27(2), 169–183. https://doi.org/10.1177/039463201402700204

Chicago

Mollbrink, A, R Jawad, A Vlamis-Gardikas, P Edenvik, B Isaksson, O Danielsson, P Stål, and A P Fernandes. 2014. “Expression of Thioredoxins and Glutaredoxins in Human Hepatocellular Carcinoma: Correlation to Cell Proliferation, Tumor Size and Metabolic Syndrome.” International Journal of Immunopathology and Pharmacology 27 (2): 169–83. doi:10.1177/039463201402700204.